Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines.
Chayama K, Hayes CN, Ohishi W, Kawakami Y.
J Gastroenterol. 2013 Jan;48(1):1-12. doi: 10.1007/s00535-012-0714-9. Epub 2012 Nov 28.
Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
Kamal H, Fornes R, Simin J, Stål P, Duberg AS, Brusselaers N, Aleman S.
J Viral Hepat. 2021 Oct;28(10):1431-1442. doi: 10.1111/jvh.13577. Epub 2021 Jul 28.
Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infection.
Chayama K, Mitsui F, Hayes CN.
Expert Rev Gastroenterol Hepatol. 2015 Jan;9(1):21-30. doi: 10.1586/17474124.2015.960394. Epub 2014 Sep 14.
Hepatitis delta and HIV infection.
Calle Serrano B, Manns MP, Wedemeyer H.
Semin Liver Dis. 2012 May;32(2):120-9. doi: 10.1055/s-0032-1316467. Epub 2012 Jul 3.
Hepatitis delta: immunopathogenesis and clinical challenges.
Grabowski J, Wedemeyer H.
Dig Dis. 2010;28(1):133-8. doi: 10.1159/000282076. Epub 2010 May 7.
Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates.
Mehawej M, Rostaing L, Alric L, Del Bello A, Izopet J, Kamar N.
J Transplant. 2015;2015:159795. doi: 10.1155/2015/159795. Epub 2015 Jul 16.
Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024.
Adepoju VA, Udah DC, Adnani QES.
Viruses. 2024 Oct 31;16(11):1723. doi: 10.3390/v16111723.
Treatment for Hepatitis C Virus Infection in Adults.
Chou R, Hartung D, Rahman B, Wasson N, Cottrell E, Fu R.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov. Report No.: 12(13)-EHC113-EF.
Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
Liaw YF, Tsai SL, Sheen IS, Chao M, Yeh CT, Hsieh SY, Chu CM.
Am J Gastroenterol. 1998 Mar;93(3):354-9. doi: 10.1111/j.1572-0241.1998.00354.x.
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC.
AIDS. 2015 Jan 2;29(1):53-8. doi: 10.1097/QAD.0000000000000516.
